Adaptors in Toll-Like Receptor Signaling and their Potential as Therapeutic Targets
Journal:
Current Drug Targets
Volume:
13
Page:
1360-1374
Author(s):
Thomas Ve, Nicholas J. Gay, Ashley Mansell, Bostjan Kobe and Stuart Kellie
Uropathogenic Escherichia coli Mediated Urinary Tract Infection
Journal:
Current Drug Targets
Volume:
13
Page:
1386-1399
Author(s):
Makrina Totsika, Danilo Gomes Moriel, Adi Idris, Benjamin A. Rogers, Daniel J. Wurpel, Minh-Duy Phan, David L. Paterson and Mark A. Schembri
Prokaryotic Substrate-Binding Proteins as Targets for Antimicrobial Therapies
Journal:
Current Drug Targets
Volume:
13
Page:
1400-1410
Author(s):
Rafael M. Counago, Christopher A. McDevitt, Miranda P. Ween and Bostjan Kobe
Wzy-Dependent Bacterial Capsules as Potential Drug Targets
Journal:
Current Drug Targets
Volume:
13
Page:
1421-1431
Author(s):
Daniel J. Ericsson, Alistair Standish, Bostjan Kobe and Renato Morona
In Vivo Imaging of the Diseased Nervous System: An Update
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4465-4470
Author(s):
Catherine Sorbara, Thomas Misgeld and Martin Kerschensteiner
Biochemical Markers of Autoimmune Diseases of the Nervous System
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4556-4563
Author(s):
Hayrettin Tumani and Johannes Brettschneider
Management of Spasticity in Progressive Multiple Sclerosis: Efficacy of Repeated Intrathecal Triamcinolone Acetonide Administration
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4564-4569
Author(s):
Mazen Abu-Mugheisib, Reiner Benecke and Uwe K. Zettl
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4453-4464
Author(s):
Holger M. Reichardt and Fred Luhder
Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4570-4582
Author(s):
Alexander Winkelmann and Uwe K. Zettl
Animal Models in Neurology: Drawbacks and Opportunities
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
4443-4452
Author(s):
Robert Patejdl and Uwe K. Zettl